AzTrials
AzTrials

Noise ExposureNCT05774977

Broadband Sound and Sleep

A study testing Aviation Noise Only (AN), Pink noise only, 50 dBA (BN50) and Aviation Noise With Earplugs (AN+EP) in people with Noise Exposure, run by University of Pennsylvania at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Sound insulation of bedrooms is expensive and typically only granted to residents living close to the airport. We plan to investigate the effects of various aviation noises on sleep under controlled laboratory conditions and to investigate whether some of the sleep disturbing effects can be mitigated by introducing… Read more about this study

Who is it for?
Ages 21 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Noise Exposure
What is being tested?
Aviation Noise Only (AN), Pink noise only, 50 dBA (BN50) and Aviation Noise With Earplugs (AN+EP)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
27 participants
Where
1 siteUnited States
Study dates
31 Oct 2023to 17 Jun 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Adult subjects between 21-50 years old
  • Free of psychological/psychiatric conditions that preclude participation.
  • BMI between 18.5 and 35.
  • Self-reported regular sleep schedule; able to maintain their sleep schedule during the course of the study.
  • Self-reported sleep duration of 6-8.5 h per night (verified by ambulatory sleep monitoring with wrist actigraphy and daily logs).
  • Ability to read/write English.
  • Fully vaccinated for or recovered from coronavirus (COVID-19).

Who cannot join

  • Subjects habitually use broadband noise (e.g. white noise machines) to promote sleep at home.
  • Hearing loss greater than 25 dB in any frequency band up to 8 kilohertz (kHz).
  • History of neurological, psychiatric, or other medical condition that excludes participation.
  • Current mania or psychosis.
  • Current depression as determined by the Beck Depression Inventory with a score of 17 or greater (Beck, 1996).
  • Alcohol or drug abuse in the past year based upon history and urine toxicology screen.
Show all 22Show fewer
  • Excessive alcohol intake (above 21 drinks per week) or binge alcohol consumption (5 or more drinks per day).
  • Excessive caffeine consumption (above 650mg/day combining all caffeinated drinks regularly absorbed during the day).
  • Current smoker/tobacco user, or using nicotine replacement therapy. Those that have been nicotine-free for 30 days will be included.
  • Body Mass Index at or below 18.5 or at or above 35.
  • Acute, chronic, or debilitating medical conditions, major Axis I psychiatric illness based on history, physical exam, blood and urine chemistries, and complete blood count (CBC).
  • Individuals who self-report a history of recurrent seizures or epilepsy or have a history of medical conditions that could increase the chance of seizures (e.g. stroke, aneurysm, brain surgery, structural brain lesion).
  • Cardiovascular, neurological, gastrointestinal, or musculoskeletal problems that exclude participation.
  • Major controlled or uncontrolled medical condition such as congestive heart failure, neuromuscular disease, renal failure, cancer, chronic obstructive pulmonary disease (COPD), respiratory failure or insufficiency, cardiac arrhythmia, or patients requiring oxygen therapy (as determined by self-report).
  • Currently working night, swing, split or rotating shift.
  • Current use or use of within the past month of a prescription or over-the-counter sleep medication or stimulant; use of psychoactive medication (based on self-report and review with a study clinician).
  • Pregnant or currently breast feeding.
  • Prior history or diagnosis of any sleep disorder including Obstructive Sleep Apnea (OSA) (AHI at or above 15 events/hour) from ambulatory or in lab polysomnography; Restless legs syndrome or periodic limb movement disorder; Insomnia; Parasomnia; High Risk of OSA based on Stop-Bang Questionnaire (yes on at least 4 of 8 questions); High Risk of Restless Legs Syndrome (RLS) based on Cambridge-Hopkins Screening questionnaire; High Risk of Insomnia based on Insomnia Severity Index (score of 22 or higher).
  • Individuals who self-report severe contact dermatitis or allergy to silicone, nickel or silver.
  • Planned travel across more than one time zone one month prior to and/or during the anticipated period of the study.
  • Intentional naps during the week.
  • Positive COVID-19 test at prescreening.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Pennsylvania Perelman School of Medicine

    Philadelphia, Pennsylvania, 19104

Other trials in United States

About this study

Official title: Study on the Use of Broadband Sound to Mitigate Sleep Disruption Due to Aircraft Noise

Sound insulation of bedrooms is expensive and typically only granted to residents living close to the airport. We plan to investigate the effects of various aviation noises on sleep under controlled laboratory conditions and to investigate whether some of the sleep disturbing effects can be mitigated by introducing broadband noise into the bedroom or by wearing earplugs.

Read the detailed description

The Federal Aviation Administration is interested in investigating inexpensive yet effective methods to mitigate the adverse effects of aviation noise on sleep. The sleep of up to 28 subjects will be monitored with polysomnography and actigraphy over 7 consecutive nights in groups of 4 exposed to various sound conditions (aviation noise; broadband noise; aviation noise plus earplugs; aviation noise plus broadband noise at various decibel [dB] levels). Subjects will fill out surveys, perform cognitive tasks and a hearing test before and after each sleep period. The study will be performed in the Chronobiology Isolation Laboratory (CIL) in the Hospital of the University of Pennsylvania. This newly constructed facility includes 4 acoustically isolated bedrooms and a high-fidelity sound system. Eligible subjects are age 21-50, free of psychiatric conditions that preclude participation, and maintain a self-reported regular sleep schedule of 6-8.5 hours per night as verified by six days of ambulatory actigraphy and daily logs.

Conditions
Noise Exposure
Being tested
Aviation Noise Only (AN), Pink noise only, 50 dBA (BN50), Aviation Noise With Earplugs (AN+EP), Aviation Noise With Pink Noise, 40 dBA (AN+BN40), Aviation Noise With Pink Noise, 50 dBA (AN+BN50)
Keywords
Sleep, Cognitive Performance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Aviation Noise Only (AN)Other

    The aviation noise (AN) night will expose subjects to a pre-programmed recording of aviation noise and alerts during sleep from 2300-0700.

  • Pink noise only, 50 dBA (BN50)Other

    The BN50 night will consist of exposure to continuous pink noise throughout the sleep period at a level of 50 A-weighted decibels (dBA).

  • Aviation Noise With Earplugs (AN+EP)Other

    The AN + EP night will consist of the aviation noise (AN) exposure with the addition of wearing earplugs overnight.

  • Aviation Noise With Pink Noise, 40 dBA (AN+BN40)Other

    The AN + BN40 night will consist of the aviation noise (AN) exposure with the addition of continuous pink noise throughout the sleep period at a level of 40 dBA.

  • Aviation Noise With Pink Noise, 50 dBA (AN+BN50)Other

    The AN + BN50 night will consist of the aviation noise (AN) exposure with the addition of continuous pink noise throughout the sleep period at a level of 50 dBA.

Study groups in NCT05774977
Study groupRoleWhat they receive
Pink Noise Only, 50 dBA (BN50)ExperimentalSubjects were exposed to six different conditions during a sleep opportunity period from 2300-0700. After an adaptation night with no interventions on night 1, subjects received the Pink Noise at 50 dBA (BN50) condition once between nights 2 to 7. The Pink Noise at 50 dBA (BN50) night consisted of exposure to continuous pink broadband noise throughout the sleep period at a level of 50 A-weighted decibels (dBA). For the purposes of blinding, this was Condition A.
Receives: Other: Aviation Noise Only (AN); Other: Pink noise only, 50 dBA (BN50); Other: Aviation Noise With Earplugs (AN+EP); Other: Aviation Noise With Pink Noise, 40 dBA (AN+BN40); Other: Aviation Noise With Pink Noise, 50 dBA (AN+BN50)
Aviation Noise Plus Pink Noise at 50 dBA (AN+BN50)ExperimentalSubjects were exposed to six different conditions during a sleep opportunity period from 2300-0700. After an adaptation night with no interventions on night 1, subjects received the Aviation Noise + Pink Noise at 50 dBA (AN+BN50) condition once between nights 2-7. The Aviation Noise plus Pink Noise, 50 dBA (AN+BN50) night consisted of aviation noise (AN) exposure with the addition of continuous pink noise throughout the sleep period at a level of 50 dBA (BN50). The aviation noise (AN) was a pre-programmed recording of 93 sounds including aviation-related noise (e.g. helicopter, sonic boom) and alerting noise (alarm, baby crying), ranging from 45 dB to 65 dB, played during sleep from 2300-0700. For the purposes of blinding, this was Condition B.
Receives: Other: Aviation Noise Only (AN); Other: Pink noise only, 50 dBA (BN50); Other: Aviation Noise With Earplugs (AN+EP); Other: Aviation Noise With Pink Noise, 40 dBA (AN+BN40); Other: Aviation Noise With Pink Noise, 50 dBA (AN+BN50)
Control (CTRL)Sham comparatorSubjects were exposed to six different conditions during a sleep opportunity period from 2300-0700. After an adaptation night with no interventions on night 1, subjects received the Control (CTRL) condition once between nights 2 to 7. The Control (CTRL) night had no interventions. There was no background broadband noise nor aviation noise, and subjects did not wear earplugs. For the purposes of blinding, this was Condition C.
Receives: Other: Aviation Noise Only (AN); Other: Pink noise only, 50 dBA (BN50); Other: Aviation Noise With Earplugs (AN+EP); Other: Aviation Noise With Pink Noise, 40 dBA (AN+BN40); Other: Aviation Noise With Pink Noise, 50 dBA (AN+BN50)
Aviation Noise Plus Pink Noise at 40 dBA (AN+BN40)ExperimentalSubjects were exposed to six different conditions during a sleep opportunity period from 2300-0700. After an adaptation night with no interventions on night 1, subjects received the Aviation Noise plus Pink Noise at 40 dBA (AN+BN40) condition once between nights 2 to 7. The Aviation Noise plus Pink Noise at 40 dBA (AN + BN40) night consisted of the aviation noise (AN) exposure with the addition of continuous pink noise throughout the sleep period at a level of 40 A-weighted decibels (dBA). The aviation noise (AN) was a pre-programmed recording of 93 sounds including aviation-related noise (e.g. helicopter, sonic boom) and alerting noise (alarm, baby crying), ranging from 45 dB to 65 dB, played during sleep from 2300-0700. For the purposes of blinding, this was Condition D.
Receives: Other: Aviation Noise Only (AN); Other: Pink noise only, 50 dBA (BN50); Other: Aviation Noise With Earplugs (AN+EP); Other: Aviation Noise With Pink Noise, 40 dBA (AN+BN40); Other: Aviation Noise With Pink Noise, 50 dBA (AN+BN50)
Aviation Noise (AN)ExperimentalSubjects were exposed to six different conditions during a sleep opportunity period from 2300-0700. After an adaptation night with no interventions on night 1, subjects received the Aviation Noise (AN) condition once between nights 2 to 7. The aviation noise (AN) was a pre-programmed recording of 93 sounds including aviation-related noise (e.g. helicopter, sonic boom) and alerting noise (alarm, baby crying), ranging from 45 dB to 65 dB, played during sleep from 2300-0700. There was no broadband noise exposure overnight. For the purposes of blinding, this was Condition E.
Receives: Other: Aviation Noise Only (AN); Other: Pink noise only, 50 dBA (BN50); Other: Aviation Noise With Earplugs (AN+EP); Other: Aviation Noise With Pink Noise, 40 dBA (AN+BN40); Other: Aviation Noise With Pink Noise, 50 dBA (AN+BN50)
Aviation Noise Plus Earplugs (AN+EP)ExperimentalSubjects were exposed to six different conditions during a sleep opportunity period from 2300-0700. After an adaptation night with no interventions on night 1, subjects received the Aviation Noise plus Earplugs (AN+EP) condition once between nights 2 to 7. The aviation noise (AN) was a pre-programmed recording of 93 sounds including aviation-related noise (e.g. helicopter, sonic boom) and alerting noise (alarm, baby crying), ranging from 45 dB to 65 dB, played during sleep from 2300-0700. There was no broadband noise exposure. For the purposes of blinding, this was Condition F.
Receives: Other: Aviation Noise Only (AN); Other: Pink noise only, 50 dBA (BN50); Other: Aviation Noise With Earplugs (AN+EP); Other: Aviation Noise With Pink Noise, 40 dBA (AN+BN40); Other: Aviation Noise With Pink Noise, 50 dBA (AN+BN50)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time Spent in Slow Wave Sleep and Rapid Eye Movement (N3 + REM)

    Combined time spent in sleep stages N3 and REM in minutes, as measured by polysomnography (PSG).

    Measured: Days 2-7

Secondary outcomes (4)
  1. Cognition Efficiency

    Efficiency scores from 10 brief cognitive tasks are generated from accuracy \& speed of reaction/responding, represented here by standardized effect sizes, where higher scores indicate better performance. Test scores were adjusted for practice and stimulus set effects, and z-transformed based on average and standard deviation across all tests taken. Accuracy and speed across cognitive domains were calculated by averaging z-scores across the 10 tests, then averaged to calculate an efficiency metric.

    Scores between -0.2 and +0.2 suggest no effect on efficiency (0=population mean).

    Between -0.2 and -0.5 suggests a small negative effect (i.e. slightly less efficient).

    Between -0.5 and -0.8 suggests a moderate negative effect. Scores below -0.8 suggest a large negative effect. Between 0.2 and 0.5 suggests a small positive effect. Between 0.5 and 0.8 suggests a moderate positive effect. Scores above 0.8 suggest a large positive effect (i.e. significantly more efficient).

    Measured: Days 2-7

  2. Cognition Speed

    A single variable representing response time across 10 Cognitive tasks that cover a range of cognitive domains with known cerebral representation. Test scores were adjusted for practice and stimulus set effects, and z-transformed based on average and standard deviation across all tests taken. Speed across cognitive domains was calculated by averaging z-scores across the 10 tests. Higher scores reflect faster speed.

    Scores between -0.2 and +0.2 suggest no effect on speed (0=population mean). Between -0.2 and -0.5 suggests a small negative effect (i.e. slightly slower). Between -0.5 and -0.8 suggests a moderate negative effect. Scores below -0.8 suggest a large negative effect (i.e. significantly slower). Between 0.2 and 0.5 suggests a small positive effect (i.e. slightly faster). Between 0.5 and 0.8 suggests a moderate positive effect. Scores above 0.8 suggest a large positive effect (i.e. significantly faster).

    Measured: Days 2-7

  3. Cognition Accuracy

    A single variable representing response time across 10 Cognitive tasks that cover a range of cognitive domains with known cerebral representation. Test scores were adjusted for practice and stimulus set effects, and z-transformed based on average and standard deviation across all tests taken. Accuracy across cognitive domains was calculated by averaging z-scores across the 10 tests. Higher scores reflect better accuracy.

    Scores between -0.2 and +0.2 suggest no effect on accuracy (0=population mean). Between -0.2 and -0.5 suggests a small negative effect (i.e. slightly less accurate).

    Between -0.5 and -0.8 suggests a moderate negative effect. Scores below -0.8 suggest a large negative effect (i.e. significantly less accurate).

    Between 0.2 and 0.5 suggests a small positive effect (i.e. slightly more accurate).

    Between 0.5 and 0.8 suggests a moderate positive effect. Scores above 0.8 suggest a large positive effect (i.e. significantly more accurate).

    Measured: Days 2-7

  4. Driving Simulator Standard Deviation of Lane Position

    The standard deviation of lane position reflects the extent (in feet) to which participants "swerve" within the lane in a virtual driving simulator, often used to investigate the effects of impairment on driving performance, where higher values represent worse performance.

    Measured: Days 2-7

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2023
  2. Study start31 Oct 2023
  3. Primary completion17 Jun 2024
  4. Study completion17 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Model description
We will investigate participants in 7 groups of 4 subjects each. For six nights following an adaptation night, a different noise condition occurred each night. Each participant of a group was exposed to the same condition in each study night. In this randomization paradigm, each condition will appear in each position exactly once, and will be preceded by each other condition exactly once.
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
27 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05774977
Sponsor's protocol ID
852479
Status last verified
Nov 2025
First submitted
7 Mar 2023
Last updated
18 Nov 2025
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Public project data files will be available via the National Transportation Library (NTL). Personally Identifiable Information (PII) will not be publicly available. Sensitive data that cannot be de-identified will be posted to secure government databases, such as posting of genetic sequence data in NIH's database of Genotypes and Phenotypes (dbGAP) (www.ncbi.nlm.nih.gov/gap/), where appropriate and in accordance with institutional review board (IRB) guidance and federal regulations.

Publications

  • Huang HW, Zheng BL, Jiang L, Lin ZT, Zhang GB, Shen L, Xi XM. Effect of oral melatonin and wearing earplugs and eye masks on nocturnal sleep in healthy subjects in a simulated intensive care unit environment: which might be a more promising strategy for ICU sleep deprivation? Crit Care. 2015 Mar 19;19(1):124. doi: 10.1186/s13054-015-0842-8.

    PubMed 25887528
  • Riedy SM, Smith MG, Rocha S, Basner M. Noise as a sleep aid: A systematic review. Sleep Med Rev. 2021 Feb;55:101385. doi: 10.1016/j.smrv.2020.101385. Epub 2020 Sep 9.

    PubMed 33007706
  • Watson NF, Badr MS, Belenky G, Bliwise DL, Buxton OM, Buysse D, Dinges DF, Gangwisch J, Grandner MA, Kushida C, Malhotra RK, Martin JL, Patel SR, Quan SF, Tasali E. Recommended Amount of Sleep for a Healthy Adult: A Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society. Sleep. 2015 Jun 1;38(6):843-4. doi: 10.5665/sleep.4716.

    PubMed 26039963
  • Basner M, McGuire S. WHO Environmental Noise Guidelines for the European Region: A Systematic Review on Environmental Noise and Effects on Sleep. Int J Environ Res Public Health. 2018 Mar 14;15(3):519. doi: 10.3390/ijerph15030519.

    PubMed 29538344
  • Basner M, Babisch W, Davis A, Brink M, Clark C, Janssen S, Stansfeld S. Auditory and non-auditory effects of noise on health. Lancet. 2014 Apr 12;383(9925):1325-1332. doi: 10.1016/S0140-6736(13)61613-X. Epub 2013 Oct 30.

    PubMed 24183105
  • Basner M, Smith MG, Cordoza M, Kayser MS, Carlin M, Ecker AJ, Gilad Y, Park-Chavar S, Rennie K, Schneller V, Walsh S, Shou H, Cao Q, Younes M, Aeschbach D, Jones CW. The efficacy of pink noise and earplugs for mitigating sleep disruption induced by different environmental noise sources. Sleep Health. 2026 Aug;12(4):702-706. doi: 10.1016/j.sleh.2026.03.009. Epub 2026 May 13.

    PubMed 42120238
  • Basner M, Smith MG, Cordoza M, Kayser MS, Carlin M, Ecker AJ, Gilad Y, Park-Chavar S, Rennie K, Schneller V, Walsh S, Shou H, Cao Q, Younes M, Aeschbach D, Jones CW. Efficacy of pink noise and earplugs for mitigating the effects of intermittent environmental noise exposure on sleep. Sleep. 2026 May 12;49(5):zsag001. doi: 10.1093/sleep/zsag001.

    PubMed 41627391

Questions about this trial

What is this clinical trial studying?

A study testing Aviation Noise Only (AN), Pink noise only, 50 dBA (BN50) and Aviation Noise With Earplugs (AN+EP) in people with Noise Exposure, run by University of Pennsylvania at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 22 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 18 Nov 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time Spent in Slow Wave Sleep and Rapid Eye Movement (N3 + REM) (time frame: Days 2-7). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05774977, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in